Text and Data Mining valid from 2017-01-31
Received: 18 May 2016
Accepted: 21 December 2016
First Online: 31 January 2017
: There is potential competing interest. Teruo Okano is a founder and a member of the board of CellSeed Inc., which has licenses for certain cell sheet-related technologies and patents from Tokyo Women’s Medical University. Tatsuya Shimizu and Teruo Okano are shareholders of CellSeed Inc. Tokyo Women’s Medical University is receiving research funds from CellSheed Inc.